InvestorsHub Logo

frequent1

03/18/21 10:55 AM

#125447 RE: 66Mustang #125446

I'm afraid I don't see it as a good thing. I see the competition doing what we are afraid to tackle head on. For example, we spent time and money on a surgeon training platform. What's the point of a trg platform if we haven't even attained design freeze? They got approval without a training platform in place. We shudder at the sound of de Novo, as we were led to believe time and cost projections would be astronomical, when as noted it is a pathway for low to moderate risk devices = "much easier approval process" as you point out. We should have had our single port system by now. Clinical trials not till end of next year? FDA in 2023? What is the delay?
aimho

SPORT19

03/18/21 4:38 PM

#125464 RE: 66Mustang #125446

I think you should watch this video before you think enos will get approved for transvaginal hysterectomies anytime soon.
Highly unlikely enos snake arms have anywhere close to the dexterity and flexibility as this platform. They are accessing transvaginaly
yet they are working as if the have accessed through the abdomen!!
Truly remarkable......
There are other differences as well that you should be able to figure out.
Hominis looks like a true game changer and it’s already got FDA approval.